TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 43, Issue 1, 2000, Pages 129-134

  Rood, M J ^a   Van Krugten, M V ^a   Zanelli, E ^a   Van Der Linden, M W ^a   Keijsers, V ^a   Schreuder, G M T ^a   Verduyn, W ^a   Westendorp, R G J ^a   De Vries, R R P ^a   Breedveld, F C ^a   Verweij, C L ^a   Huizinga, T W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN; TUMOR NECROSIS FACTOR;

ADULT; ALLELISM; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR3 ANTIGEN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034045545     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200001)43:1<129::AID-ANR16>3.0.CO;2-S     Document Type: Article

References (33)

1. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, et al. Systemic lupus crythematosus in three ethnic groups. I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. Arthritis Rheum 1998;41:1161-72.
2. Cowland JB, Andersen V, Halberg P, Morling N. DNA polymorphism of HLA class II genes in systemic lupus erythematosus. Tissue Antigens 1994;43:34-7.
3. Davies EJ, Hillarby MC, Cooper RG, Hay EM, Green JR, Shah S, et al. HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus. Br J Rheumatol 1993;32:870-5.
4. Reveille JD, Anderson KL, Schrohenloher RE, Acton RT, Barger BE. Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus. J Rheumatol 1991;18:14-8.
5. Hartung K, Baur MP, Coldewey R, Fricke M, Kalden JR, Lakomek HJ, et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. J Clin Invest 1992;90:1346-51.
6. Skarsvag S, Hansen KE, Holst A, Moen T. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes? Tissue Antigens 1992;40:128-33.
7. Lu L-Y, Ding W-Z, Fici D, Deulofeut R, Cheng H-H, Cheu C-C, et al. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997;40:1138-45.
8. Hashimoto H, Nishimura Y, Dong RP, Kimura A, Sasazuki T, Yumanaka K, et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 1994;23:191-6.
9. Hong GH, Kim HY, Takeuchi F, Nakano K, Yamada H, Matsuta K, et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans. J Rheumatol 1994;21: 442-7.
10. Balkwill FR. Tumour necrosis factor. Br Med Bull 1989;45:389-400.
11. Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor a and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996;35:1067-74.
12. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7.
13. Fujimura T, Hirose S, Jiang Y, Kodera S, Ohmoro H, Zhang D, et al. Dissection of the effects of tumor necrosis factor a and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Int Immunol 1998;10:1467-72.
14. Chen CJ, Yen JH, Tsai WC, Wu CS, Chiang W, Tsai JJ, et al. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett 1997;55:1-3.
15. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LB, Emery P. et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor α. Eur J Immunol 1994;24:191-5.
16. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes GR, et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996;23:1725-8.
17. Sullivan KE, Woolen C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997;40:2207-11.
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
19. Westendorp RG, Langcrmans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349: 170-3.
20. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1982.
21. Verduyn W, Doxiadis IIN, Anholts J, Drabbels JJM, Naipal A, D'Amaro J, et al. Biotinylated DRB sequence-specific oligonucleotides: comparison to serologic HLA-DR typing of organ donors in Eurotransplant. Hum Immunol 1993;37:59-67.
22. Terasaki PI, Gjcrlson DW. HLA 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1997.
23. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1090-5.
24. Silva LM, Donadi EA. Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE? Ann Rheum Dis 1996;55:544-7.
25. Rood MJ, Keijsers V, van der Linden MW, Tong TOT, Borggreve S, Verweij CL, et al. Neuropsychiatric SLE is associated with imbalance in IL-10 promoter haplotypes. Ann Rheum Dis 1999; 58:85-9.
26. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-10.
27. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, et al. Polymorphism in tumor necrosis factor genes associated with mucocutancous leishmaniasis. J Exp Med 1995; 182:1259-64.
28. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-9.
29. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997;34:391-9.
30. Brinkman BM, Zuijdgeest D, Kaijzel EL, Breedveld FC. Verweij CL. Relevance of the tumor necrosis factor α (TNF α)-308 promoter polymorphism in TNF α gene regulation. J Inflamm 1996;46:32-41.
31. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, et al. 308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996;46:42-50.
32. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, et al. TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997;72:149-53.
33. Grumet FC, Coukell A, Bodmer JG, Bodmer WF, McDevitt HO. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus: a possible genetic predisposition to disease. N Engl J Med 1971;285:193-6.